Latest Breaking News On - Guggenheim nantucket therapeutics conference - Page 1 : comparemela.com

Xilio Therapeutics to Present at Guggenheim Nantucket Therapeutics Conference

Xilio Therapeutics to Present at Guggenheim Nantucket Therapeutics Conference
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Myles cloustonviceJulissa vianaviceXilio therapeutics incCorporate communicationsLinkedin xilio therapeutics incWall streetGuggenheim nantucket therapeutics conferenceXilio therapeuticsInvestor inquiriesMyles cloustonvice presidentMedia inquiriesJulissa vianavice president

Xilio Therapeutics to Present at Guggenheim Nantucket

WALTHAM, Mass., Sept. 22, 2022 (GLOBE NEWSWIRE) Xilio Therapeutics, Inc. (Nasdaq: XLO), a biotechnology company developing tumor-selective.

Julissa vianaMyles cloustonXilio therapeutics incCorporate communicationsLinkedin xilio therapeutics incGuggenheim nantucket therapeutics conferenceXilio therapeuticsInvestor inquiriesMedia inquiriesNasdaq xloXilio therapeutics

Praxis Precision Medicines to Present at Guggenheim Nantucket Therapeutics Conference

21.09.2022 - BOSTON, Sept. 21, 2022 (GLOBE NEWSWIRE) - Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system (CNS) disorders .

United statesPraxis precision medicines incPrecision medicinesGuggenheim nantucket therapeutics conference

Seelos Therapeutics to Participate in the Guggenheim Nantucket Therapeutics Conference

NEW YORK, Sept. 9, 2022 /PRNewswire/ Seelos Therapeutics, Inc. (Nasdaq: SEEL), a clinical-stage biopharmaceutical company focused on the develo.

New yorkUnited statesYatin sunejaRaj mehraMike moyerAnthony marcianoPrnewswire seelos therapeutics incLifesci advisorsSeelos therapeutics incGuggenheim nantucket therapeutics conferenceSenior biotechnology analyst yatin sunejaAcute suicidal ideationMajor depressive disorderSci advisors

Centessa Pharmaceuticals to Participate in Upcoming Investor Conferences

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

New yorkUnited statesKristenk sheppardMorgan stanleyResearch developmentCentessa pharmaceuticalsAnnual global healthcare conferenceNew york cityAnnual global investment conferenceGuggenheim nantucket therapeutics conferenceGlobe newswire